These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
252 related items for PubMed ID: 19240076
1. Comparative in vitro activity of REP3123 against Clostridium difficile and other anaerobic intestinal bacteria. Citron DM, Warren YA, Tyrrell KL, Merriam V, Goldstein EJ. J Antimicrob Chemother; 2009 May; 63(5):972-6. PubMed ID: 19240076 [Abstract] [Full Text] [Related]
2. Spectrum of activity and mode of action of REP3123, a new antibiotic to treat Clostridium difficile infections. Critchley IA, Green LS, Young CL, Bullard JM, Evans RJ, Price M, Jarvis TC, Guiles JW, Janjic N, Ochsner UA. J Antimicrob Chemother; 2009 May; 63(5):954-63. PubMed ID: 19258353 [Abstract] [Full Text] [Related]
3. Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection model. Ochsner UA, Bell SJ, O'Leary AL, Hoang T, Stone KC, Young CL, Critchley IA, Janjic N. J Antimicrob Chemother; 2009 May; 63(5):964-71. PubMed ID: 19251726 [Abstract] [Full Text] [Related]
4. Comparative in vitro activities of XRP 2868, pristinamycin, quinupristin-dalfopristin, vancomycin, daptomycin, linezolid, clarithromycin, telithromycin, clindamycin, and ampicillin against anaerobic gram-positive species, actinomycetes, and lactobacilli. Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez HT, Bryskier A. Antimicrob Agents Chemother; 2005 Jan; 49(1):408-13. PubMed ID: 15616322 [Abstract] [Full Text] [Related]
9. Activity of OPT-80, a novel macrocycle, compared with those of eight other agents against selected anaerobic species. Credito KL, Appelbaum PC. Antimicrob Agents Chemother; 2004 Nov; 48(11):4430-4. PubMed ID: 15504874 [Abstract] [Full Text] [Related]
14. In vitro activities of doripenem and comparator agents against 364 anaerobic clinical isolates. Wexler HM, Engel AE, Glass D, Li C. Antimicrob Agents Chemother; 2005 Oct; 49(10):4413-7. PubMed ID: 16189137 [Abstract] [Full Text] [Related]
15. [Antagonistic activity of Lactobacillus bacteria strains against anaerobic gastrointestinal tract pathogens (Helicobacter pylori, Campylobacter coli, Campylobacter jejuni, Clostridium difficile)]. Strus M, Pakosz K, Gościniak H, Przondo-Mordarska A, Rozynek E, Pituch H, Meisel-Mikołajczyk F, Heczko PB. Med Dosw Mikrobiol; 2001 Oct; 53(2):133-42. PubMed ID: 11757422 [Abstract] [Full Text] [Related]
16. In vitro activities of dalbavancin and 12 other agents against 329 aerobic and anaerobic gram-positive isolates recovered from diabetic foot infections. Goldstein EJ, Citron DM, Warren YA, Tyrrell KL, Merriam CV, Fernandez HT. Antimicrob Agents Chemother; 2006 Aug; 50(8):2875-9. PubMed ID: 16870792 [Abstract] [Full Text] [Related]